Accordingly, PRMT5 promotes disease progression in mouse models of oncogene-driven leukemia20 and its depletion reduces proliferation of B cell lymphoma cells18,19,21. The gene discussed is PRMT5; the disease is B-cell non-Hodgkin lymphoma.